A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia
Authors:
- N. Anim-NyameNAN. Anim-Nyame
- F.A. HillsFHF.A. Hills
- P.J. SteerPSP.J. Steer
Open Access
- 1 October 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 15 (10) , 2215-2219
Abstract
Insulin-like growth factor binding protein-1 (IGFBP-1) is synthesized by the decidual stroma, and is thought to act locally to inhibit IGF activity and so limit trophoblast invasion. Cross-sectional studies have reported conflicting data on maternal circulating concentrations of IGFBP-1 in early pregnancy before the development of pre-eclampsia. A longitudinal study was performed in 10 women who went on to develop pre-eclampsia and a group of 12 normal pregnant controls, chosen to be similar for maternal age, booking body mass index (BMI) and gestational age. Maternal IGFBP-1 concentrations were measured in plasma obtained at 16, 20, 24, 28, 32 and 36 weeks. Plasma IGFBP-1 concentrations were unchanged over this period in normal pregnancy. In contrast, the concentrations in women who developed pre-eclampsia increased progressively. At 16, 20, and 24 weeks the concentrations were significantly lower compared to normal pregnancy, at 28 and 32 weeks, similar, but by 36 weeks the concentrations were significantly greater than the normal controls. The data show that circulating IGFBP-1 concentrations are lower in early pregnancy before the development of pre-eclampsia. Thus, it is suggested that IGFBP-1-induced inhibition of IGF activity is unlikely to be responsible for the impaired trophoblast invasion observed in pre-eclampsia.Keywords
This publication has 12 references indexed in Scilit:
- Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxiaProceedings of the National Academy of Sciences, 1998
- Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1997
- The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.The Journal of Clinical Endocrinology & Metabolism, 1996
- Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- The effects of labor on maternal and fetal levels of insulin-like growth factor binding protein-1American Journal of Obstetrics and Gynecology, 1994
- The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weightJournal of Endocrinology, 1991
- Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancyJournal of Endocrinology, 1991
- Different Insulin-like Growth Factor Binding Species in Human Placenta and Decidua*The Journal of Clinical Endocrinology & Metabolism, 1988
- Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblastsBiochemical and Biophysical Research Communications, 1988
- The classification and definition of the hypertensive disorders of pregnancyAmerican Journal of Obstetrics and Gynecology, 1988